Difference between revisions of "ELOC-mutated renal cell carcinoma"

Jump to navigation Jump to search

ELOC-mutated renal cell carcinoma (view source)

Revision as of 20:16, 20 December 2023

110 bytes removed ,  20:16, 20 December 2023
m
no edit summary
m
Line 116: Line 116:
NEGATIVE: CK34betaE12, CK20.
NEGATIVE: CK34betaE12, CK20.


The staining and morphology raises the possibility of a ELOC-mutated renal cell carcinoma (RCC).
The differential diagnosis includes: (1) clear cell renal cell carcinoma, (2) RCC with a mTOR pathway mutation, and (3) ELOC-mutated RCC.


The differential diagnosis includes: (1) RCC with a mTOR pathway mutation, and (2) ELOC-mutated RCC.
Clear cell renal cell carcinoma is not excluded.
</pre>
</pre>


Michael
48,874

edits

Retrieved from "https://librepathology.org/wiki/Special:MobileDiff/52599"

Navigation menu